EDWIN CALDERON: Open Payments
NPI 1437350873 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,009 in 149 payments from 16 companies in 2025. Trend: 2023 $2,973 · 2024 $2,985 · 2025 $4,009
Food & beverage: $3,509Consulting: $500
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 59 | $1,427 |
| Gilead Sciences, Inc. | 30 | $764 |
| Theratechnologies Inc. | 7 | $702 |
| Merck Sharp & Dohme LLC | 9 | $325 |
| Otsuka America Pharmaceutical, Inc. | 15 | $217 |
| EMD Serono, Inc. | 12 | $203 |
| Exact Sciences Corporation | 3 | $83 |
| Bausch Health US, LLC | 3 | $68 |
| Kowa Pharmaceuticals America, Inc. | 3 | $53 |
| Paratek Pharmaceuticals, Inc. | 2 | $48 |
Products named: EGRIFTA, DOVATO, APRETUDE, CABENUVA, Biktarvy, REXULTI, PIFELTRO, RUKOBIA.
Industry payments across NY — which companies pay providers there.
